Idera Pharmaceuticals (IDRA) & Oncobiologics (ONS) Critical Contrast

Idera Pharmaceuticals (IDRA) & Oncobiologics (ONS) Critical Contrast

Idera Pharmaceuticals and Oncobiologics are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. 42.5% of Idera Pharmaceuticals shares are owned by institutional investors.

from Biotech News